The Aerogen Solo can support aerosol drug delivery at every stage of a patient’s respiratory journey: during invasive mechanical ventilation, non-invasive support such as non-invasive ventilation (NIV), high-flow (HF) therapies and when self-ventilating.
Quick and easy to set up
Virtually silent
Single patient use
28 days intermittent or 7 days continuous use
No added flow
Refill medication cup without opening the circuit
6 mL cup
Can be placed at the wye or at the humidifier
Effectiveness
Aerogen facilitates effective medication delivery across multiple respiratory modalities
In studies, ~4x more drug deposition was achieved with Aerogen during invasive mechanical ventilation, NIV‡5, and HF,6 and ~6x more drug deposition when self-ventilating‡ versus jet nebulisers
Patient care
Aerogen improves patient care in response to aerosolised medication
In studies assessing bronchodilator delivery across several respiratory modalities, Aerogen Solo, when compared with jet nebulisers, was associated with:
Improvements in lung function in patients undergoing NIV
Comparable bronchodilator efficacy‡ during high-flow
Reductions in hospital admission rates, ED median length of stay, and in the number of treatments and time required to achieve symptom control§ in self-ventilating patients
Workflow
Aerogen simplifies the workflow
Aerogen Solo is intended for the aerosolisation of physician-prescribed solutions for inhalation
One system can be used throughout a patient's respiratory journey (IMV, NIV, HF, self-ventilating), supporting continuity of care